Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Henzen

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 24, 2005
Discrepancy between second and first opinion in surgical oncological patientsW A M Mellink, S C Henzen-Logmans, A H H Bongaerts, et al.
International Journal of Cancer|September 9, 1992
Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancerE M Berns, J G Klijn, S C Henzen-Logmans, et al.
British Journal of Cancer|January 1, 1992
Stromal influences on breast cancer cell growthC E van Roozendaal, B van Ooijen, J G Klijn, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Phase I studies of rodorubicin single bolus and daily times five, once every three weeks in patients with advanced solid tumorsJ Verweij, M E van der Burg, W L van Putten, et al.
International Journal of Cancer|December 20, 1996
Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumorsM E van der Burg, S C Henzen-Logmans, E M Berns, et al.
International Journal of Cancer|May 14, 1998
High prevalence of codon 213Arg-->Stop mutations of the TP53 gene in human ovarian cancer in the southwestern part of The NetherlandsM Schuyer, S C Henzen-Logmans, M E van der Burg, et al.
Journal of Internal Medicine|December 23, 2014
Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up studyM Alan, E Grolimund, A Kutz, et al.
Diabetes Care|June 17, 2000
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertensionJ Valabhji, S Robinson, C Poulter, et al.
Molecular and Cellular Endocrinology|April 28, 1995
Transforming growth factor beta secretion from primary breast cancer fibroblastsC E van Roozendaal, J G Klijn, B van Ooijen, et al.
Journal of Clinical Pathology|February 14, 1998
A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative GroupP J van Diest, P van Dam, S C Henzen-Logmans, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 24, 2005
Discrepancy between second and first opinion in surgical oncological patientsW A M Mellink, S C Henzen-Logmans, A H H Bongaerts, et al.
International Journal of Cancer|September 9, 1992
Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancerE M Berns, J G Klijn, S C Henzen-Logmans, et al.
British Journal of Cancer|January 1, 1992
Stromal influences on breast cancer cell growthC E van Roozendaal, B van Ooijen, J G Klijn, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Phase I studies of rodorubicin single bolus and daily times five, once every three weeks in patients with advanced solid tumorsJ Verweij, M E van der Burg, W L van Putten, et al.
International Journal of Cancer|December 20, 1996
Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumorsM E van der Burg, S C Henzen-Logmans, E M Berns, et al.
International Journal of Cancer|May 14, 1998
High prevalence of codon 213Arg-->Stop mutations of the TP53 gene in human ovarian cancer in the southwestern part of The NetherlandsM Schuyer, S C Henzen-Logmans, M E van der Burg, et al.
Journal of Internal Medicine|December 23, 2014
Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up studyM Alan, E Grolimund, A Kutz, et al.
Diabetes Care|June 17, 2000
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertensionJ Valabhji, S Robinson, C Poulter, et al.
Molecular and Cellular Endocrinology|April 28, 1995
Transforming growth factor beta secretion from primary breast cancer fibroblastsC E van Roozendaal, J G Klijn, B van Ooijen, et al.
Journal of Clinical Pathology|February 14, 1998
A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative GroupP J van Diest, P van Dam, S C Henzen-Logmans, et al.
Pageof 11